3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
23
Lung Neoplasms
12
Prostatic Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
8
Breast Neoplasms
5
Stomach Neoplasms
4
Prostatic Neoplasms, Castration-Resistant
4
Neoplasms
4
Neoplasm Metastasis
3
Endometrial Neoplasms
3
Carcinoma, Transitional Cell
3
Carcinoma
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Carcinoma
2
Melanoma
2
Lymphoid Interstitial Pneumonia
2
Head and Neck Neoplasms
2
HER2-positive Breast Cancer
2
Esophageal Neoplasms
2
Anatomic Stage I Breast Cancer AJCC v8
2
Vaccinia
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Tongue Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Solid Tumors
1
Interventions
Magnetic Resonance Spectroscopy
4
Specimen Handling
3
lutetium Lu 177 dotatate
2
Bevacizumab
2
regorafenib
1
olaparib
1
neratinib
1
gallium Ga 68 dotatate
1
capivasertib
1
cabozantinib
1
brigatinib
1
abemaciclib
1
Watchful Waiting
1
Tablets
1
Surveys and Questionnaires
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Protons
1
Proton Therapy
1
Observation
1
Nivolumab
1
Lysine
1
Ipilimumab
1
Hydroxyurea
1
HhAntag691
1
Ga(III)-DOTATOC
1
GSK2256098
1
Everolimus
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Meningioma
×
Docetaxel
×
30 days
×
Clear all
No trials found.